◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksA › AGL

agilon health Inc (AGL) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL CARE FACILITIES · DATA UPDATED 2026-09-15

agilon health Inc (AGL) operates in the MEDICAL CARE FACILITIES industry and is headquartered in Westerville, United States with about 856 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, AGL reported $5.9B in revenue and ($405M) in net income.

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc.

Interactive charts & full statements → Open the AGL valuation workbench →

AGL Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Total Revenue$5.9B$5.9B$6.1B$4.3B$2.4B$1.5B$1.2B$794M
Gross Profit$0M($189M)$5M$70M$111M$66M$94M$29M
Gross Margin %0.0%-3.2%0.1%1.6%4.7%4.3%7.7%3.6%
Operating Income (EBIT)($265M)($421M)($292M)($232M)($105M)($372M)($57M)($107M)
Operating Margin %-4.5%-7.1%-4.8%-5.4%-4.4%-24.5%-4.7%-13.4%
Net Income($251M)($405M)($260M)($263M)($107M)($406M)($60M)($283M)
Net Margin %-4.2%-6.8%-4.3%-6.1%-4.5%-26.7%-4.9%-35.6%
EBITDA($234M)($369M)($218M)($168M)($72M)($362M)($40M)($64M)
Earnings Per Share (EPS)$-15.19$-24.48$-15.83$-16.05$-6.53$-27.25$-3.90$-18.40
Shares Outstanding (M)17M17M16M16M16M15M15M15M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AGL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$1.5B$1.4B$1.6B$1.4B$1.4B$1.5B$1.5B$1.5B
Gross Profit$107M$58M($98M)($68M)($52M)$51M($38M)($64M)
Gross Margin %7.2%4.1%-6.2%-4.7%-3.8%3.3%-2.5%-4.4%
Operating Income (EBIT)$12M$10M($156M)($131M)($116M)($22M)($108M)($134M)
Operating Margin %0.8%0.7%-9.9%-9.2%-8.3%-1.4%-7.1%-9.2%
Net Income$18M$30M($189M)($110M)($104M)$12M($106M)($118M)
Net Margin %1.2%2.1%-12.0%-7.7%-7.5%0.8%-7.0%-8.1%
EBITDA$11M$35M($179M)($101M)($95M)$7M($97M)($109M)
Earnings Per Share (EPS)$1.04$1.80$-11.39$-6.65$-6.31$0.73$-6.42$-7.14
Shares Outstanding (M)17M17M17M17M17M17M16M16M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AGL Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Cash from Operations (CFO)($72M)($106M)($58M)($156M)($131M)($148M)($53M)($104M)
Capital Expenditures (CapEx)$40M$13M$13M$31M$33M$13M$2M$4M
Free Cash Flow (FCF)($112M)($119M)($71M)($187M)($163M)($162M)($56M)($108M)
FCF Margin %-1.9%-2.0%-1.2%-4.3%-6.8%-10.6%-4.6%-13.6%
Dividends Paid$7M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AGL Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)($57M)$24M($21M)($18M)($35M)($32M)$16M($8M)
Capital Expenditures (CapEx)$3M$3M$17M$17M$3M$11M$12M$14M
Free Cash Flow (FCF)($61M)$21M($38M)($35M)($38M)($43M)$4M($22M)
FCF Margin %-4.1%1.5%-2.4%-2.4%-2.8%-2.8%0.3%-1.5%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AGL Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Total Assets$1.6B$1.3B$1.7B$1.7B$1.7B$1.6B$446M$403M
Cash & Cash Equivalents$107M$174M$194M$114M$465M$1.1B$107M$124M
Total Liabilities$1.4B$1.1B$1.3B$1.1B$657M$495M$731M$635M
Total Debt (Short + Long-Term)$30M$35M$37M$41M$43M$52M$68M$70M
Total Shareholders' Equity$228M$127M$471M$662M$1.0B$1.1B($285M)($232M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AGL viewer.

Other Companies in MEDICAL CARE FACILITIES

← AGIXAll “A” companiesAGM →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.